SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-20-003043
Filing Date
2020-04-28
Accepted
2020-04-28 18:14:44
Documents
1
Period of Report
2020-04-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8471
  Complete submission text file 0000919574-20-003043.txt   11064
Mailing Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Reporting) CIK: 0001278386 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 20826496

Mailing Address 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY 10019
Business Address 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD CAPITAL INC (Reporting) CIK: 0001278387 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 20826497

Mailing Address
Business Address
BRADSHER NEAL C (Reporting) CIK: 0001278388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 20826498

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances